Fluorodeoxyglucose (FDG) uptake in pulmonary rheumatoid nodules diagnosed by video-assisted thoracic surgery lung biopsy: two case reports and a review of the literature
Takeshi Saraya1 , Ryota Tanaka2 , Masachika Fujiwara3 , Hitoshi Koji4 , Miku Oda1 , Yukari Ogawa1 , Tomoko Nagatomo1 , Masato Watanabe1 , Takuma Yokoyama1 , Haruyuki Ishii1 , Hidefumi Takei2 , Tomoyuki Goya2, Hajime Takizawa1, Hajime Goto1
27 July 2011
1 May 2012
6 June 2012
PDF (member's only)
Two cases of rheumatoid nodules evaluated by fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) and video-assisted thoracic surgery (VATS) biopsy are reported. The first case was that of a 44-year-old woman who presented with a cavitated nodule with intense standardized uptake values (SUVs) both in the early (max 3.4) and delayed (max 4.4) phases, suggesting malignancy. However, after VATS biopsy, she was diagnosed as having a rheumatoid nodule with vasculitis. The second case was that of a 74-year-old woman admitted with bilateral lung nodules, two of which showed intense early (max 2.2) and delayed (max 6.0) phase SUVs, and mild early (max 0.6) and delayed (max 0.9) phase SUVs. These two nodules were finally proven to be a lung cancer and rheumatoid nodule without vasculitis, respectively. These cases show that rheumatoid nodules with an enhanced inflammatory process, such as vasculitis, can appear false-positive for malignancy on FDG-PET/CT scan images.
Video-assisted thoracic surgery - Rheumatoid nodule - FDG-PET - Lung cancer - Vasculitis